Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Omer Junaidi"'
Publikováno v:
American Journal of Gastroenterology. 117:e1999-e2000
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14e993ca09bc71888cb28dbc20df686b
https://doi.org/10.14309/01.ajg.0000869092.04650.f0
https://doi.org/10.14309/01.ajg.0000869092.04650.f0
Autor:
Anish Patel, Seth Sclair, Omer Junaidi, Violet Copado, Cynthia Levy, Paul Martin, Madhavi Rudraraju, Kalyan R Bhamidimarri
Publikováno v:
Journal of Gastroenterology and Hepatology Research. 3:1335-1339
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47feff1a04f68dacba5de7541f676f74
https://doi.org/10.17554/j.issn.2224-3992.2014.03.470
https://doi.org/10.17554/j.issn.2224-3992.2014.03.470
Autor:
Omer Junaidi, Jonathan Krakover, Brent Kopenhaver, Lucy Rodemich, Mengjun Wang, Adrian M. Di Bisceglie, Anand Mehta, Julie Hafner, Timothy M. Block, Mary Ann Comunale, Ronald E. Long
Publikováno v:
Journal of Proteome Research. 8:595-602
Changes in N-linked glycosylation are known to occur during the development of cancer. For example, we have previously reported changes in N-linked glycosylation that occur with the development of hepatocellular carcinoma (HCC) and, through the use o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ba544b0f5f14a50f642f3dab600e67a
https://doi.org/10.1021/pr800752c
https://doi.org/10.1021/pr800752c
Autor:
Brian O'Sullivan, Steven D. Freedman, Meredith M. Regan, Michel Warny, Munir M. Zaman, Ciaran P. Kelly, Andres Gelrud, Omer Junaidi, Julie C. Shea
Publikováno v:
Clinical and Vaccine Immunology. 11:819-824
Patients with cystic fibrosis (CF) exhibit an excessive host inflammatory response. The aim of this study was to determine (i) whether interleukin 8 (IL-8) secretion is increased from monocytes from subjects heterozygous as well as homozygous for cys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8c3141ce884bed0ddcc8f2b8162e59c
https://doi.org/10.1128/cdli.11.5.819-824.2004
https://doi.org/10.1128/cdli.11.5.819-824.2004
Autor:
Rhonda K. Yantiss, Imad Nasser, Munir M. Zaman, Omer Junaidi, Paola G. Blanco, Steven D. Freedman, Sunil A Sheth
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 287:G491-G496
It is unknown why some patients with inflammatory bowel disease develop primary sclerosing cholangitis. We have recently shown that patients with primary sclerosing cholangitis have an increased prevalence of mutations in the gene responsible for cys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5541634a052e64f2e145f1fb38817aca
https://doi.org/10.1152/ajpgi.00452.2003
https://doi.org/10.1152/ajpgi.00452.2003
Autor:
Steven D. Freedman, Iphigenia Tzameli, Paola G. Blanco, Charlotte Andersson, Adolfo A. Ferrando, Omer Junaidi, Mario Ollero, Munir M. Zaman, Eldad Bialecki
Publikováno v:
Journal of Cellular Physiology. 200:235-244
Some of the pathological manifestations of cystic fibrosis are in accordance with an impaired expression and/or activity of PPARgamma. We hypothesized that PPARgamma expression is altered in tissues lacking the normal cystic fibrosis transmembrane re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22d5d2c1c6fcd78c3c731c155e7273fe
https://doi.org/10.1002/jcp.20020
https://doi.org/10.1002/jcp.20020
Publikováno v:
Journal of gastrointestinal oncology. 2(3)
Pancreatic cancer (PaCa) is the fourth leading cause of cancer-related death in the United States. The median size of pancreatic adenocarcinoma at the time of diagnosis is about 31 mm and has not changed significantly in last three decades despite ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cdd9c0528deca3eabf31b6d29e533926
https://pubmed.ncbi.nlm.nih.gov/22811847
https://pubmed.ncbi.nlm.nih.gov/22811847
Publikováno v:
Missouri medicine. 106(5)
Chronic liver disease is the tenth leading cause of death in the United States. The economic burden of liver disease is approximately 1% of the total national health care expenditure. Chronic hepatitis C is the most common cause of chronic liver dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::236d5e0b871086ebab4988aa6849d236
https://pubmed.ncbi.nlm.nih.gov/19902718
https://pubmed.ncbi.nlm.nih.gov/19902718
Autor:
Jorge A. Marrero, Mengjun Wang, Omer Junaidi, Mary Ann Comunale, Ronald E. Long, Anand Mehta, Timothy M. Block, Adrian M. Di Bisceglie
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(6)
Changes in glycosylation, most notably fucosylation, have been associated with the development of hepatocellular carcinoma (HCC). In this report, the levels of fucosylated kininogen (Fc-Kin) and fucosylated α-1-antitrypsin were analyzed individually
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13b802d742260185e99b1f2722ea63d6
https://pubmed.ncbi.nlm.nih.gov/19454616
https://pubmed.ncbi.nlm.nih.gov/19454616
Autor:
Omer Junaidi, Adrian M. Di Bisceglie
Publikováno v:
Clinics in geriatric medicine. 23(4)
Chronic liver disease and cirrhosis are the tenth leading causes of death in the United States and results in approximately 25,000 deaths annually. As life expectancy in developed countries has increased, so has the number of elderly patients who hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaeac4430d6171d597bfd869de87d4de
https://pubmed.ncbi.nlm.nih.gov/17923344
https://pubmed.ncbi.nlm.nih.gov/17923344